Increased levels of IL-22 protein have been reported in the serum, but not the CSF, of patients with active MS (Perriard et al., 2015), while IL-22 has been found to be expressed in the CNS early in the development of EAE in the rat (Almolda et al., 2011). This evidence concerns the gene IL22 and myeloid sarcoma.